Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.
Revelation Biosciences has raised $11.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Revelation Biosciences's investors include National Securities Corporation, Global Health Funds.
Revelation Biosciences is headquartered in Menlo Park, United States.
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.
Revelation Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Revelation Biosciences — Funding & Investors." VCBacked, January 23, 2026, https://www.vcbacked.co/company/revelation-biosciences. Accessed August 17, 2026.
VCBacked. (2026). Revelation Biosciences — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/revelation-biosciences
{{cite web |title=Revelation Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/revelation-biosciences |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated